Capillary Endoscopy Aspiration Catheter
Launched by CEDARS-SINAI MEDICAL CENTER · Jun 1, 2020
Trial Information
Current as of July 21, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying a new type of device called a capillary endoscopy aspiration catheter, which is designed to help doctors collect fluid samples from the small intestine more efficiently. The small intestine is an important area for research on bacteria that live in our bodies, but collecting samples from it can be tricky with current tools. This new catheter is inspired by how plants drink water and aims to improve the way fluid is suctioned during endoscopy, making it faster and less likely to be contaminated.
To participate in this study, you need to be between 18 and 85 years old and scheduled for an esophagogastroduodenoscopy, which is a procedure that allows doctors to examine the upper part of the digestive system. The trial will involve two groups of patients, where one will use the standard catheter and the other will use the new capillary catheter. Each group will have 23 participants, and the researchers will compare how long it takes to collect samples and how much fluid is gathered. There are no specific health conditions that would exclude you from participating, as the procedures are being done for medical reasons. This study could help improve future methods of studying the small intestine and its bacteria.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Male or female subjects aged 18-85 undergoing esophagogastroduodenoscopy.
- Exclusion Criteria:
- • There are no exclusion criteria for this study as subjects will be undergoing the procedures for medical reasons and not for the purposes of this study.
About Cedars Sinai Medical Center
Cedars-Sinai Medical Center is a renowned nonprofit academic medical center located in Los Angeles, California, recognized for its commitment to patient care, research, and education. As a leading institution in clinical trials, Cedars-Sinai harnesses innovative approaches to advance medical knowledge and improve treatment outcomes across various specialties. With a multidisciplinary team of experts, state-of-the-art facilities, and a patient-centered approach, Cedars-Sinai actively contributes to the development of novel therapies and interventions, ensuring the highest standards of clinical research while prioritizing patient safety and ethical considerations.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Los Angeles, California, United States
Patients applied
Trial Officials
Ali Rezaie, MD
Principal Investigator
Cedars-Sinai Medical Center
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials